[
  {
    "id": "3f19655a-d1c7-4948-b646-e603ac15cd45",
    "tenantId": "gilead",
    "assessmentName": "Gilead Sciences - Immunology Assessment",
    "geographicScope": "Global",
    "ipStrategy": "Proprietary",
    "currentScore": 0,
    "maxPossibleScore": 100,
    "status": "template",
    "version": "1.0",
    "completedAt": null,
    "completedBy": null,
    "createdAt": "2025-09-13T09:29:49.746Z",
    "updatedAt": "2025-09-13T09:29:49.746Z",
    "tenant": {
      "id": "gilead",
      "name": "Gilead Sciences",
      "industryType": "Biotechnology",
      "description": "Biotechnology company focused on antiviral therapies, oncology, and rare diseases",
      "website": "https://www.gilead.com",
      "subscriptionTier": "enterprise",
      "isActive": true,
      "createdAt": "2025-09-12T21:42:16.073Z",
      "therapeuticFocus": [
        "infectious_disease",
        "oncology",
        "rare_disease",
        "immunology"
      ],
      "aiInitiatives": [
        "drug_discovery",
        "clinical_trial",
        "patient_monitoring"
      ],
      "deploymentScenarios": [
        "clinical_trial",
        "drug_discovery",
        "post_market"
      ]
    },
    "therapeuticAreas": [
      {
        "id": "immunology",
        "name": "Immunology",
        "complexityPoints": 14,
        "regulatoryRequirements": null,
        "specificOverlays": null
      }
    ],
    "aiModelTypes": [],
    "deploymentScenarios": [],
    "learningInsights": []
  },
  {
    "id": "3a8fd4e7-2fdb-4222-b94f-78f336b333b3",
    "tenantId": "gilead",
    "assessmentName": "Gilead Sciences - Rare Disease Assessment",
    "geographicScope": "Global",
    "ipStrategy": "Proprietary",
    "currentScore": 0,
    "maxPossibleScore": 100,
    "status": "template",
    "version": "1.0",
    "completedAt": null,
    "completedBy": null,
    "createdAt": "2025-09-13T09:29:49.745Z",
    "updatedAt": "2025-09-13T09:29:49.745Z",
    "tenant": {
      "id": "gilead",
      "name": "Gilead Sciences",
      "industryType": "Biotechnology",
      "description": "Biotechnology company focused on antiviral therapies, oncology, and rare diseases",
      "website": "https://www.gilead.com",
      "subscriptionTier": "enterprise",
      "isActive": true,
      "createdAt": "2025-09-12T21:42:16.073Z",
      "therapeuticFocus": [
        "infectious_disease",
        "oncology",
        "rare_disease",
        "immunology"
      ],
      "aiInitiatives": [
        "drug_discovery",
        "clinical_trial",
        "patient_monitoring"
      ],
      "deploymentScenarios": [
        "clinical_trial",
        "drug_discovery",
        "post_market"
      ]
    },
    "therapeuticAreas": [
      {
        "id": "rare_disease",
        "name": "Rare Disease",
        "complexityPoints": 20,
        "regulatoryRequirements": null,
        "specificOverlays": null
      }
    ],
    "aiModelTypes": [],
    "deploymentScenarios": [],
    "learningInsights": []
  },
  {
    "id": "0500148f-e855-40d6-ba17-5b0cbb8f72b2",
    "tenantId": "gilead",
    "assessmentName": "Gilead Sciences - Oncology Assessment",
    "geographicScope": "Global",
    "ipStrategy": "Proprietary",
    "currentScore": 0,
    "maxPossibleScore": 100,
    "status": "template",
    "version": "1.0",
    "completedAt": null,
    "completedBy": null,
    "createdAt": "2025-09-13T09:29:49.743Z",
    "updatedAt": "2025-09-13T09:29:49.743Z",
    "tenant": {
      "id": "gilead",
      "name": "Gilead Sciences",
      "industryType": "Biotechnology",
      "description": "Biotechnology company focused on antiviral therapies, oncology, and rare diseases",
      "website": "https://www.gilead.com",
      "subscriptionTier": "enterprise",
      "isActive": true,
      "createdAt": "2025-09-12T21:42:16.073Z",
      "therapeuticFocus": [
        "infectious_disease",
        "oncology",
        "rare_disease",
        "immunology"
      ],
      "aiInitiatives": [
        "drug_discovery",
        "clinical_trial",
        "patient_monitoring"
      ],
      "deploymentScenarios": [
        "clinical_trial",
        "drug_discovery",
        "post_market"
      ]
    },
    "therapeuticAreas": [
      {
        "id": "oncology",
        "name": "Oncology",
        "complexityPoints": 15,
        "regulatoryRequirements": null,
        "specificOverlays": null
      }
    ],
    "aiModelTypes": [],
    "deploymentScenarios": [],
    "learningInsights": []
  },
  {
    "id": "7578f06e-98cf-4a11-a492-0db84d8cb961",
    "tenantId": "gilead",
    "assessmentName": "Gilead Sciences - Infectious Disease Assessment",
    "geographicScope": "Global",
    "ipStrategy": "Proprietary",
    "currentScore": 0,
    "maxPossibleScore": 100,
    "status": "template",
    "version": "1.0",
    "completedAt": null,
    "completedBy": null,
    "createdAt": "2025-09-13T09:29:49.739Z",
    "updatedAt": "2025-09-13T09:29:49.739Z",
    "tenant": {
      "id": "gilead",
      "name": "Gilead Sciences",
      "industryType": "Biotechnology",
      "description": "Biotechnology company focused on antiviral therapies, oncology, and rare diseases",
      "website": "https://www.gilead.com",
      "subscriptionTier": "enterprise",
      "isActive": true,
      "createdAt": "2025-09-12T21:42:16.073Z",
      "therapeuticFocus": [
        "infectious_disease",
        "oncology",
        "rare_disease",
        "immunology"
      ],
      "aiInitiatives": [
        "drug_discovery",
        "clinical_trial",
        "patient_monitoring"
      ],
      "deploymentScenarios": [
        "clinical_trial",
        "drug_discovery",
        "post_market"
      ]
    },
    "therapeuticAreas": [
      {
        "id": "infectious_disease",
        "name": "Infectious Disease",
        "complexityPoints": 10,
        "regulatoryRequirements": null,
        "specificOverlays": null
      }
    ],
    "aiModelTypes": [],
    "deploymentScenarios": [],
    "learningInsights": []
  },
  {
    "id": "0852d8e7-b5bb-41be-bb45-a7a7462cf614",
    "tenantId": "gilead",
    "assessmentName": "Compliance Assessment - Annual Review #017",
    "geographicScope": "APAC",
    "ipStrategy": "Proprietary",
    "currentScore": 60,
    "maxPossibleScore": 100,
    "status": "completed",
    "version": "1.0",
    "completedAt": "2025-09-27T08:01:47.295Z",
    "completedBy": "system@complianceiq.com",
    "createdAt": "2025-09-10T11:50:16.076Z",
    "updatedAt": "2025-09-10T11:50:16.076Z",
    "tenant": {
      "id": "gilead",
      "name": "Gilead Sciences",
      "industryType": "Biotechnology",
      "description": "Biotechnology company focused on antiviral therapies, oncology, and rare diseases",
      "website": "https://www.gilead.com",
      "subscriptionTier": "enterprise",
      "isActive": true,
      "createdAt": "2025-09-12T21:42:16.073Z",
      "therapeuticFocus": [
        "infectious_disease",
        "oncology",
        "rare_disease",
        "immunology"
      ],
      "aiInitiatives": [
        "drug_discovery",
        "clinical_trial",
        "patient_monitoring"
      ],
      "deploymentScenarios": [
        "clinical_trial",
        "drug_discovery",
        "post_market"
      ]
    },
    "therapeuticAreas": [
      {
        "id": "5d4310a0-6867-4fdf-a5f3-f542f3e9ec41",
        "name": "Immunotherapy Research",
        "complexityPoints": 12,
        "regulatoryRequirements": {
          "ema": true,
          "fda": true,
          "pmda": false
        },
        "specificOverlays": null
      }
    ],
    "aiModelTypes": [
      {
        "id": "84bed57b-5805-4b4f-a0e1-af72a174e3e1",
        "name": "Manufacturing Process AI",
        "complexityPoints": 10,
        "specificRequirements": {
          "monitoring": "Continuous",
          "validation": "Required",
          "documentation": "Comprehensive"
        },
        "securityConsiderations": null
      }
    ],
    "deploymentScenarios": [
      {
        "id": "83459c54-2bed-4fda-a7b9-7c24065711c8",
        "name": "Clinical Research Environment",
        "complexityPoints": 10,
        "regulatoryPathway": "FDA 510(k)",
        "validationRequirements": {
          "quality": true,
          "clinical": true,
          "manufacturing": true
        }
      }
    ],
    "learningInsights": []
  }
]
